Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  253 results for ""GLUCAGON-like peptides""

Your Filters

Subject : insulin resistance
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Effects of Tirzepatide vs Semaglutide on β-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test.

  • Authors : Mather KJ; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA.; Mari A

Subjects: Insulin-Secreting Cells*/Insulin-Secreting Cells*/Insulin-Secreting Cells*/drug effects ; Insulin-Secreting Cells*/Insulin-Secreting Cells*/Insulin-Secreting Cells*/metabolism ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/pharmacology

  • Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Nov 18; Vol. 109 (12), pp. 3046-3054.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of Semaglutide on Physical Function, Body Composition, and Biomarkers of Aging in Older Adults With Overweight and Insulin Resistance: Protocol for an Open-Labeled Randomized Controlled Trial.

  • Authors : Cortes TM; Division of Endocrinology, Department of Medicine, University of Texas Health Science Center San Antonio, San Antonio, TX, United States.; Sam & Ann Barshop Institute for Longevity & Aging Studies, University of Texas Health Science Center San Antonio, San Antonio, TX, United States.

Subjects: Biomarkers*/Biomarkers*/Biomarkers*/blood ; Body Composition*/Body Composition*/Body Composition*/drug effects ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: JMIR research protocols [JMIR Res Protoc] 2024 Sep 13; Vol. 13, pp. e62667. Date of Electronic Publication: 2024 Sep 13.Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101599504 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Tirzepatide Improved Markers of Islet Cell Function and Insulin Sensitivity in People With T2D (SURPASS-2).

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism

  • Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Jun 17; Vol. 109 (7), pp. 1745-1753.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Semaglutide 6-months therapy of type 2 diabetes mellitus restores adipose progenitors potential to develop metabolically active adipocytes.

  • Authors : Stafeev I; National Medical Research Centre of Cardiology Named After Academician E.I.Chazov, 121552, Moscow, Russia. Electronic address: .; Agareva M

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism ; Insulin Resistance*/Insulin Resistance*/Insulin Resistance*/physiology

  • Source: European journal of pharmacology [Eur J Pharmacol] 2024 May 05; Vol. 970, pp. 176476. Date of Electronic Publication: 2024 Mar 15.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology.

  • Authors : Dwibedi C; Department of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.; Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.

Subjects: Benzhydryl Compounds* ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Glucagon-Like Peptides*

  • Source: Nature metabolism [Nat Metab] 2024 Jan; Vol. 6 (1), pp. 50-60. Date of Electronic Publication: 2024 Jan 04.Publisher: Springer Nature Country of Publication: Germany NLM ID: 101736592 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of once weekly dulaglutide by baseline beta-cell function in people with type 2 diabetes in the AWARD programme.

  • Authors : Mathieu C; Clinical and Experimental Endocrinology, University of Leuven, Leuven, Belgium.; Del Prato S

Subjects: Insulin Resistance*; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*agonists

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2018 Aug; Vol. 20 (8), pp. 2023-2028. Date of Electronic Publication: 2018 May 02.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Differential effects of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide and metformin on pancreatic β-cell and insulin sensitivity during a standardized test meal in patients with type 2 diabetes.

  • Authors : Mari A; National Research Council, Institute of Neuroscience, Padova, Italy.; Del Prato S

Subjects: Insulin Resistance*; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptides/Glucagon-Like Peptides/Glucagon-Like Peptides/*analogs & derivatives

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2016 Aug; Vol. 18 (8), pp. 834-9. Date of Electronic Publication: 2016 May 16.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Evaluation of intragastric vs intraperitoneal glucose tolerance tests in the evaluation of insulin resistance in a rodent model of burn injury and glucagon-like polypeptide-1 treatment.

  • Authors : Watada S; From the *Burn Unit, Department of Surgery, Massachusetts General Hospital, Harvard Medical School and Shriners Hospital for Children®; and †Shriners Hospital for Children®, Boston, Massachussets.

Subjects: Burns/Burns/Burns/*blood ; Burns/Burns/Burns/*drug therapy ; Glucagon-Like Peptides/Glucagon-Like Peptides/Glucagon-Like Peptides/*pharmacology

  • Source: Journal of burn care & research : official publication of the American Burn Association [J Burn Care Res] 2014 Jan-Feb; Vol. 35 (1), pp. e66-72.Publisher: Oxford University Press Country of Publication: England NLM ID: 101262774 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Marked Improvement of Insulin Sensitivity Without Enhancement of GLP-1 and Insulin Secretion After Roux-en-Y Gastric Bypass Surgery in a Mildly Obese Patient with Diabetes.

Subjects: *INSULIN resistance; *GLUCAGON-like peptides; *GLUCAGON-like peptide 1

  • Source: Hormone & Metabolic Research. Jun2014, Vol. 46 Issue 6, p424-426. 3p.

Record details

Read More Add to Saved list
×
Academic Journal

Farnesoid X receptor: An important factor in blood glucose regulation.

Subjects: *GLUCAGON-like peptides; *FARNESOID X receptor; *BLOOD sugar

  • Source: Clinica Chimica Acta. Aug2019, Vol. 495, p29-34. 6p.

Record details

Read More Add to Saved list
×
  • 1-10 of  253 results for ""GLUCAGON-like peptides""